Marchionni Lab Surfing the Genome

Blog

Some of our thoughts on a few things follows below

biology medicine breast-cancer prognosis gene-expression cancer class-prediction epigenomics bioconductor bioinformatics data-analysis omics tumor-heterogenity tumor-modeling acute-myeloid-leukemia transplantation clonal-hematopoiesis tumor-evolution gene-signature notch-signaling triple-negative-breast-cancer neoadjuvant-chemotherapy structural-variants metabolism immunotherapy
Showing 3 of 10 results
Clear search

2024

Notch gene signature for neoadjuvant chemotherapy response in triple-negative breast cancer
Notch gene signature for neoadjuvant chemotherapy response in triple-negative breast cancer
member portrait Luigi Marchionni, M.D., Ph.D. Lead Scientist Weill Cornell Medicine
November 15, 2024 February 26, 2025
gene-signature cancer class-prediction notch-signaling triple-negative-breast-cancer neoadjuvant-chemotherapy

Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer

2023

Using biological constraints to improve prediction in precision oncology
Using biological constraints to improve prediction in precision oncology
member portrait Luigi Marchionni, M.D., Ph.D. Lead Scientist Weill Cornell Medicine
March 17, 2023 February 26, 2025
gene-signature cancer class-prediction notch-signaling triple-negative-breast-cancer neoadjuvant-chemotherapy

Using biological constraints to improve prediction in precision oncology

REPAC: analysis of alternative polyadenylation from RNA-sequencing data
REPAC: analysis of alternative polyadenylation from RNA-sequencing data
member portrait Luigi Marchionni, M.D., Ph.D. Lead Scientist Weill Cornell Medicine
February 10, 2023 February 26, 2025
gene-signature cancer class-prediction notch-signaling triple-negative-breast-cancer neoadjuvant-chemotherapy

REPAC: analysis of alternative polyadenylation from RNA-sequencing data

2022

2021

2013